{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T23:04:43Z","timestamp":1774652683339,"version":"3.50.1"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/2.0"},{"start":{"date-parts":[[2008,6,15]],"date-time":"2008-06-15T00:00:00Z","timestamp":1213488000000},"content-version":"vor","delay-in-days":14,"URL":"https:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["All Asth Clin Immun"],"published-print":{"date-parts":[[2008,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Although there is much circumstantial evidence implicating eosinophils as major orchestrators in the pathophysiology of asthma, recent studies have cast doubt on their importance. Not only does anti-interleukin-5 treatment not alter the course of the disease, but some patients with asthma do not have eosinophils in their airways, whereas patients with eosinophilic bronchitis exhibit a florid tissue eosinophilia but do not have asthma. In contrast, mast cells are found in all airways and localize specifically to key tissue structures such as the submucosal glands and airway smooth muscle within asthmatic bronchi, irrespective of disease severity or phenotype. Here they are activated and interact exclusively with these structural cells via adhesive pathways and through the release of soluble mediators acting across the distance of only a few microns. The location of mast cells within the airway smooth muscle bundles seems particularly important for the development and propagation of asthma, perhaps occurring in response to, and then serving to aggravate, an underlying abnormality in asthmatic airway smooth muscle function. Targeting this mast cell-airway smooth muscle interaction in asthma offers exciting prospects for the treatment of this common disease.<\/jats:p>","DOI":"10.1186\/1710-1492-4-2-84","type":"journal-article","created":{"date-parts":[[2010,5,12]],"date-time":"2010-05-12T18:21:16Z","timestamp":1273688476000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Asthma: Eosinophil Disease, Mast Cell Disease, or Both?"],"prefix":"10.1186","volume":"4","author":[{"given":"Peter","family":"Bradding","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,6,15]]},"reference":[{"issue":"Suppl 2","key":"60_CR1","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1046\/j.1365-2222.1999.00016.x","volume":"29","author":"ST Holgate","year":"1999","unstructured":"Holgate ST, Lackie PM, Davies DE: The bronchial epithelium as a key regulator of airway inflammation and remodelling in asthma. Clin Exp Allergy. 1999, 29 (Suppl 2): 90-5. 10.1046\/j.1365-2222.1999.00016.x.","journal-title":"Clin Exp Allergy"},{"key":"60_CR2","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1136\/thorax.57.8.677","volume":"57","author":"NG Carroll","year":"2002","unstructured":"Carroll NG, Mutavdzic S, James AL: Increased mast cells and neutrophils in submucosal mucous glands and mucus plugging in patients with asthma. Thorax. 2002, 57: 677-82. 10.1136\/thorax.57.8.677.","journal-title":"Thorax"},{"key":"60_CR3","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1164\/ajrccm\/141.5_Pt_1.1327","volume":"141","author":"M Ebina","year":"1990","unstructured":"Ebina M, Yaegashi H, Chiba R: Hyperreactive site in the airway tree of asthmatic patients revealed by thickening of bronchial muscles. A morphometric study. Am Rev Respir Dis. 1990, 141: 1327-32.","journal-title":"Am Rev Respir Dis"},{"key":"60_CR4","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1164\/ajrccm\/148.3.720","volume":"148","author":"M Ebina","year":"1993","unstructured":"Ebina M, Takahashi T, Chiba T, Motomiya M: Cellular hypertrophy and hyperplasia of airway smooth muscles underlying bronchial asthma. A 3-D morphometric study. Am Rev Respir Dis. 1993, 148: 720-6.","journal-title":"Am Rev Respir Dis"},{"key":"60_CR5","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1164\/rccm.200409-1220OC","volume":"171","author":"CE Brightling","year":"2005","unstructured":"Brightling CE, Ammit AJ, Kaur D: The CXCL10\/CXCR3 axis mediates human lung mast cell migration to asthmatic airway smooth muscle. Am J Respir Crit Care Med. 2005, 171: 1103-8. 10.1164\/rccm.200409-1220OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"60_CR6","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/j.jaci.2006.02.039","volume":"117","author":"P Bradding","year":"2006","unstructured":"Bradding P, Walls AF, Holgate ST: The role of the mast cell in the pathophysiology of asthma. J Allergy Clin Immunol. 2006, 117: 1277-84. 10.1016\/j.jaci.2006.02.039.","journal-title":"J Allergy Clin Immunol"},{"key":"60_CR7","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1056\/NEJM199201303260504","volume":"326","author":"DS Robinson","year":"1992","unstructured":"Robinson DS, Hamid Q, Ying S: Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med. 1992, 326: 298-304. 10.1056\/NEJM199201303260504.","journal-title":"N Engl J Med"},{"key":"60_CR8","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1165\/ajrcmb.10.5.8179909","volume":"10","author":"P Bradding","year":"1994","unstructured":"Bradding P, Roberts JA, Britten KM: Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. Am J Respir Cell Mol Biol. 1994, 10: 471-80.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"60_CR9","doi-asserted-by":"publisher","first-page":"359","DOI":"10.7326\/0003-4819-139-5_Part_1-200309020-00012","volume":"139","author":"PJ Barnes","year":"2003","unstructured":"Barnes PJ, Adcock IM: How do corticosteroids work in asthma?. Ann Intern Med. 2003, 139: 359-70.","journal-title":"Ann Intern Med"},{"key":"60_CR10","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1001\/archinte.1922.00110120002001","volume":"30","author":"HL Huber","year":"1922","unstructured":"Huber HL, Koessler KK: The pathology of bronchial asthma. Arch Intern Med. 1922, 30: 689-95.","journal-title":"Arch Intern Med"},{"key":"60_CR11","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1164\/ajrccm\/139.3.806","volume":"139","author":"R Beasley","year":"1989","unstructured":"Beasley R, Roche WR, Roberts JA, Holgate ST: Cellular events in the bronchi in mild asthma and after bronchial provocation. Am Rev Respir Dis. 1989, 139: 806-17.","journal-title":"Am Rev Respir Dis"},{"key":"60_CR12","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/B978-012352325-9\/50006-X","volume-title":"Immunopharmacology of the respiratory system","author":"P Bradding","year":"1995","unstructured":"Bradding P, Walls AF, Church MK: Mast cells and basophils: their role in initiating and maintaining inflammatory responses. Immunopharmacology of the respiratory system. Edited by: Holgate ST. 1995, London: Academic Press, 53-84. full_text."},{"key":"60_CR13","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1164\/ajrccm\/139.3.801","volume":"139","author":"S Motojima","year":"1989","unstructured":"Motojima S, Frigas E, Loegering DA, Gleich GJ: Toxicity of eosinophil cationic proteins for guinea pig tracheal epithelium in vitro. Am Rev Respir Dis. 1989, 139: 801-5.","journal-title":"Am Rev Respir Dis"},{"key":"60_CR14","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1164\/ajrccm\/140.1.125","volume":"140","author":"GH Ayars","year":"1989","unstructured":"Ayars GH, Altman LC, McManus MM: Injurious effect of the eosinophil peroxide-hydrogen peroxide-halide system and major basic protein on human nasal epithelium in vitro. Am Rev Respir Dis. 1989, 140: 125-31.","journal-title":"Am Rev Respir Dis"},{"key":"60_CR15","first-page":"345","volume":"56","author":"E Frigas","year":"1981","unstructured":"Frigas E, Loegering DA, Solley GO: Elevated levels of the eosinophil granule major basic protein in the sputum of patients with bronchial asthma. Mayo Clin Proc. 1981, 56: 345-53.","journal-title":"Mayo Clin Proc"},{"key":"60_CR16","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/0091-6749(91)90158-K","volume":"88","author":"DH Broide","year":"1991","unstructured":"Broide DH, Gleich GJ, Cuomo AJ: Evidence of ongoing mast cell and eosinophil degranulation in symptomatic asthma airway. J Allergy Clin Immunol. 1991, 88: 637-48. 10.1016\/0091-6749(91)90158-K.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"60_CR17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0140-6736(82)91152-7","volume":"3","author":"WV Filley","year":"1982","unstructured":"Filley WV, Holley KE, Kephart GM, Gleich GJ: Identification by immunofluorescence of eosinophil granule major basic protein in lung tissues of patients with bronchial asthma. Lancet. 1982, 3 (2): 11-6. 10.1016\/S0140-6736(82)91152-7.","journal-title":"Lancet"},{"key":"60_CR18","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1164\/ajrccm.151.6.7767538","volume":"151","author":"P Bradding","year":"1995","unstructured":"Bradding P, Feather IH, Wilson S: Cytokine immunoreactivity in seasonal rhinitis: regulation by a topical corticosteroid. Am J Respir Crit Care Med. 1995, 151: 1900-6.","journal-title":"Am J Respir Crit Care Med"},{"key":"60_CR19","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1084\/jem.179.2.703","volume":"179","author":"S Dubucquoi","year":"1994","unstructured":"Dubucquoi S, Desreumaux P, Janin A: Interleukin 5 synthesis by eosinophils: association with granules and immunoglobulin dependent secretion. J Exp Med. 1994, 179: 703-8. 10.1084\/jem.179.2.703.","journal-title":"J Exp Med"},{"key":"60_CR20","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.4049\/jimmunol.169.2.1021","volume":"169","author":"P Schmid-Grendelmeier","year":"2002","unstructured":"Schmid-Grendelmeier P, Altznauer F, Fischer B: Eosinophils express functional IL-13 in eosinophilic inflammatory diseases. J Immunol. 2002, 169: 1021-7.","journal-title":"J Immunol"},{"key":"60_CR21","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1164\/ajrccm.154.5.8912771","volume":"154","author":"M Humbert","year":"1996","unstructured":"Humbert M, Durham SR, Ying S: IL-4 and IL-5 mRNA and protein in bronchial biopsies from patients with atopic and nonatopic asthma: evidence against \"intrinsic\" asthma being a distinct immunopathologic entity. Am J Respir Crit Care Med. 1996, 154: 1497-504.","journal-title":"Am J Respir Crit Care Med"},{"key":"60_CR22","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1164\/ajrccm.153.6.8665058","volume":"153","author":"M Humbert","year":"1996","unstructured":"Humbert M, Grant JA, Taborda-Barata L: High-affinity IgE receptor (FcepsilonRI)-bearing cells in bronchial biopsies from atopic and nonatopic asthma. Am J Respir Crit Care Med. 1996, 153: 1931-7.","journal-title":"Am J Respir Crit Care Med"},{"key":"60_CR23","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.4049\/jimmunol.158.7.3539","volume":"158","author":"S Ying","year":"1997","unstructured":"Ying S, Humbert M, Barkans J: Expression of IL-4 and IL-5 mRNA and protein product by CD4+ and CD8+ T cells, eosinophils, and mast cells in bronchial biopsies obtained from atopic and nonatopic (intrinsic) asthmatics. J Immunol. 1997, 158: 3539-44.","journal-title":"J Immunol"},{"key":"60_CR24","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1164\/ajrccm.151.2.7842189","volume":"151","author":"AJ Frew","year":"1995","unstructured":"Frew AJ, Chan H, Lam S, Chan-Yeung M: Bronchial inflammation in occupational asthma due to Western red cedar. Am J Respir Crit Care Med. 1995, 151: 340-4.","journal-title":"Am J Respir Crit Care Med"},{"key":"60_CR25","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1136\/thorax.57.10.875","volume":"57","author":"RH Green","year":"2002","unstructured":"Green RH, Brightling CE, Woltmann G: Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids. Thorax. 2002, 57: 875-9. 10.1136\/thorax.57.10.875.","journal-title":"Thorax"},{"key":"60_CR26","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1164\/ajrccm.160.3.9812110","volume":"160","author":"SE Wenzel","year":"1999","unstructured":"Wenzel SE, Schwartz LB, Langmack EL: Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med. 1999, 160: 1001-8.","journal-title":"Am J Respir Crit Care Med"},{"key":"60_CR27","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1136\/thx.2006.073429","volume":"62","author":"MA Berry","year":"2007","unstructured":"Berry MA, Morgan A, Shaw DE: Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma. Thorax. 2007, 62: 1043-9. 10.1136\/thx.2006.073429.","journal-title":"Thorax"},{"key":"60_CR28","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1378\/chest.130.1.244","volume":"130","author":"PM O'Byrne","year":"2006","unstructured":"O'Byrne PM: Cytokines or their antagonists for the treatment of asthma. Chest. 2006, 130: 244-50. 10.1378\/chest.130.1.244.","journal-title":"Chest"},{"key":"60_CR29","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1016\/S0140-6736(00)03496-6","volume":"356","author":"MJ Leckie","year":"2000","unstructured":"Leckie MJ, ten Brinke A, Khan J: Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet. 2000, 356: 2144-8. 10.1016\/S0140-6736(00)03496-6.","journal-title":"Lancet"},{"key":"60_CR30","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1164\/rccm.200206-525OC","volume":"167","author":"JC Kips","year":"2003","unstructured":"Kips JC, O'Connor BJ, Langley SJ: Effect of SCH55700 a humanized anti-human interleukin-5 antibody, in severe persistent asthma: a pilot study. Am J Respir Crit Care Med. 2003, 167: 1655-9. 10.1164\/rccm.200206-525OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"60_CR31","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1164\/rccm.200701-085OC","volume":"176","author":"P Flood-Page","year":"2007","unstructured":"Flood-Page P, Swenson C, Faiferman I: A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma. Am J Respir Crit Care Med. 2007, 176: 1062-71. 10.1164\/rccm.200701-085OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"60_CR32","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1172\/JCI17974","volume":"112","author":"P Flood-Page","year":"2003","unstructured":"Flood-Page P, Menzies-Gow A, Phipps S: Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics. J Clin Invest. 2003, 112: 1029-36.","journal-title":"J Clin Invest"},{"key":"60_CR33","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1016\/S0140-6736(02)11679-5","volume":"360","author":"RH Green","year":"2002","unstructured":"Green RH, Brightling CE, McKenna S: Asthma exacerbations and eosinophil counts. A randomised controlled trial. Lancet. 2002, 360: 1715-21. 10.1016\/S0140-6736(02)11679-5.","journal-title":"Lancet"},{"key":"60_CR34","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1183\/09031936.05.00091704","volume":"25","author":"G Cruse","year":"2005","unstructured":"Cruse G, Kaur D, Yang W: Activation of human lung mast cells by monomeric immunoglobulin E. Eur Respir J. 2005, 25: 858-63. 10.1183\/09031936.05.00091704.","journal-title":"Eur Respir J"},{"key":"60_CR35","first-page":"319","volume-title":"Asthma & rhinitis","author":"P Bradding","year":"2000","unstructured":"Bradding P: Mast cells in asthma. Asthma & rhinitis. Edited by: Busse WW, Holgate ST. 2000, Boston: Blackwell Scientific Publications, 319-38."},{"key":"60_CR36","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1136\/thx.2005.045260","volume":"60","author":"PH Howarth","year":"2005","unstructured":"Howarth PH, Babu KS, Arshad HS: Tumour necrosis factor (TNF{alpha}) as a novel therapeutic target in symptomatic corticosteroid-dependent asthma. Thorax. 2005, 60: 1012-8. 10.1136\/thx.2005.045260.","journal-title":"Thorax"},{"key":"60_CR37","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1164\/ajrccm.152.1.7599866","volume":"152","author":"PS Thomas","year":"1995","unstructured":"Thomas PS, Yates DH, Barnes PJ: Tumor necrosis factor-alpha increases airway responsiveness and sputum neutrophilia in normal human subjects. Am J Respir Crit Care Med. 1995, 152: 76-80.","journal-title":"Am J Respir Crit Care Med"},{"key":"60_CR38","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1136\/thorax.57.9.774","volume":"57","author":"PS Thomas","year":"2002","unstructured":"Thomas PS, Heywood G: Effects of inhaled tumour necrosis factor alpha in subjects with mild asthma. Thorax. 2002, 57: 774-8. 10.1136\/thorax.57.9.774.","journal-title":"Thorax"},{"key":"60_CR39","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1056\/NEJMoa050580","volume":"354","author":"MA Berry","year":"2006","unstructured":"Berry MA, Hargadon B, Shelley M: Evidence of a role of TNFa in refractory asthma. N Engl J Med. 2006, 354: 697-708. 10.1056\/NEJMoa050580.","journal-title":"N Engl J Med"},{"key":"60_CR40","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1136\/bmj.291.6500.923","volume":"291","author":"KC Flint","year":"1985","unstructured":"Flint KC, Leung KB, Hudspith BN: Bronchoalveolar mast cells in extrinsic asthma: a mechanism for the initiation of antigen specific bronchoconstriction. Br Med J. 1985, 291: 923-6. 10.1136\/bmj.291.6500.923.","journal-title":"Br Med J"},{"key":"60_CR41","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1124\/jpet.103.061291","volume":"309","author":"S He","year":"2004","unstructured":"He S, Aslam A, Gaca MD: Inhibitors of tryptase as mast cell-stabilizing agents in the human airways: effects of tryptase and other agonists of proteinase-activated receptor 2 on histamine release. J Pharmacol Exp Ther. 2004, 309: 119-26. 10.1124\/jpet.103.061291.","journal-title":"J Pharmacol Exp Ther"},{"key":"60_CR42","doi-asserted-by":"publisher","first-page":"2972","DOI":"10.1002\/eji.1830261224","volume":"26","author":"DC Machado","year":"1996","unstructured":"Machado DC, Horton D, Harrop R: Potential allergens stimulate the release of mediators of the allergic response from cells of mast cell lineage in the absence of sensitization with antigenspecific IgE. Eur J Immunol. 1996, 26: 2972-80. 10.1002\/eji.1830261224.","journal-title":"Eur J Immunol"},{"key":"60_CR43","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s000110050045","volume":"46","author":"AM Frenz","year":"1997","unstructured":"Frenz AM, Gibbs BF, Pearce FL: The effect of recombinant stem cell factor on human skin and lung mast cells and basophil leukocytes. Inflamm Res. 1997, 46: 35-9. 10.1007\/s000110050045.","journal-title":"Inflamm Res"},{"key":"60_CR44","doi-asserted-by":"publisher","first-page":"5287","DOI":"10.4049\/jimmunol.169.9.5287","volume":"169","author":"WR Coward","year":"2002","unstructured":"Coward WR, Okayama Y, Sagara H: NF-kappa B and TNF-alpha: a positive autocrine loop in human lung mast cells?. J Immunol. 2002, 169: 5287-93.","journal-title":"J Immunol"},{"key":"60_CR45","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1182\/blood-2002-12-3929","volume":"102","author":"S Okumura","year":"2003","unstructured":"Okumura S, Kashiwakura J, Tomita H: Identification of specific gene expression profiles in human mast cells mediated by Toll-like receptor 4 and FceRI. Blood. 2003, 102: 2547-54. 10.1182\/blood-2002-12-3929.","journal-title":"Blood"},{"key":"60_CR46","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1016\/j.jaci.2005.02.022","volume":"115","author":"CA Oskeritzian","year":"2005","unstructured":"Oskeritzian CA, Zhao W, Min HK: Surface CD88 functionally distinguishes the MCTC from the MCT type of human lung mast cell. J Allergy Clin Immunol. 2005, 115: 1162-8. 10.1016\/j.jaci.2005.02.022.","journal-title":"J Allergy Clin Immunol"},{"key":"60_CR47","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.jaci.2004.03.049","volume":"114","author":"M Kulka","year":"2004","unstructured":"Kulka M, Alexopoulou L, Flavell RA, Metcalfe DD: Activation of mast cells by double-stranded RNA: evidence for activation through Toll-like receptor 3. J Allergy Clin Immunol. 2004, 114: 174-82. 10.1016\/j.jaci.2004.03.049.","journal-title":"J Allergy Clin Immunol"},{"key":"60_CR48","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.4049\/jimmunol.170.4.1625","volume":"170","author":"JD McCurdy","year":"2003","unstructured":"McCurdy JD, Olynych TJ, Maher LH, Marshall JS: Cutting edge: distinct Toll-like receptor 2 activators selectively induce different classes of mediator production from human mast cells. J Immunol. 2003, 170: 1625-9.","journal-title":"J Immunol"},{"key":"60_CR49","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1073\/pnas.0406808102","volume":"102","author":"AD Kraneveld","year":"2005","unstructured":"Kraneveld AD, Kool M, van Houwelingen AH: Elicitation of allergic asthma by immunoglobulin free light chains. Proc Natl Acad Sci USA. 2005, 102: 1578-83. 10.1073\/pnas.0406808102.","journal-title":"Proc Natl Acad Sci USA"},{"key":"60_CR50","first-page":"86","volume":"130","author":"PA Eggleston","year":"1984","unstructured":"Eggleston PA, Kagey-Sobotka A, Schleimer RP: Interaction between hyperosmolar and IgE-mediated histamine release from basophils and mast cells. Am Rev Respir Dis. 1984, 130: 86-91.","journal-title":"Am Rev Respir Dis"},{"key":"60_CR51","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1056\/NEJMoa012705","volume":"346","author":"CE Brightling","year":"2002","unstructured":"Brightling CE, Bradding P, Symon FA: Mast cell infiltration of airway smooth muscle in asthma. N Engl J Med. 2002, 346: 1699-705. 10.1056\/NEJMoa012705.","journal-title":"N Engl J Med"},{"key":"60_CR52","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S1040-8428(99)00010-4","volume":"31","author":"P Bradding","year":"1999","unstructured":"Bradding P, Holgate ST: Immunopathology and human mast cell cytokines. Crit Rev Oncol Haematol. 1999, 31: 119-33. 10.1016\/S1040-8428(99)00010-4.","journal-title":"Crit Rev Oncol Haematol"},{"key":"60_CR53","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1189\/jlb.68.1.38","volume":"68","author":"D Sanmugalingam","year":"2000","unstructured":"Sanmugalingam D, Wardlaw AJ, Bradding P: Adhesion of human lung mast cells to bronchial epithelium: evidence for a novel carbohydrate-mediated mechanism. J Leuk Biol. 2000, 68: 38-46.","journal-title":"J Leuk Biol"},{"key":"60_CR54","doi-asserted-by":"crossref","first-page":"275","DOI":"10.4049\/jimmunol.156.1.275","volume":"156","author":"JA Cairns","year":"1996","unstructured":"Cairns JA, Walls AF: Mast cell tryptase is a mitogen for epithelial cells. Stimulation of IL-8 production and intercellular adhesion molecule-1 expression. J Immunol. 1996, 156: 275-83.","journal-title":"J Immunol"},{"key":"60_CR55","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1111\/j.1398-9995.2006.01041.x","volume":"61","author":"W Yang","year":"2006","unstructured":"Yang W, Wardlaw AJ, Bradding P: Attenuation of human lung mast cell degranulation by bronchial epithelium. Allergy. 2006, 61: 569-75. 10.1111\/j.1398-9995.2006.01041.x.","journal-title":"Allergy"},{"key":"60_CR56","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1111\/j.1365-2559.1978.tb01735.x","volume":"2","author":"E Cutz","year":"1978","unstructured":"Cutz E, Levison H, Cooper DM: Ultrastructure of airways in children with asthma. Histopathology. 1978, 2: 407-21. 10.1111\/j.1365-2559.1978.tb01735.x.","journal-title":"Histopathology"},{"key":"60_CR57","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1164\/ajrccm.160.2.9810100","volume":"160","author":"CE Brightling","year":"1999","unstructured":"Brightling CE, Ward R, Goh KL: Eosinophilic bronchitis is an important cause of chronic cough. Am J Respir Crit Care Med. 1999, 160: 406-10.","journal-title":"Am J Respir Crit Care Med"},{"key":"60_CR58","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1136\/thorax.58.6.528","volume":"58","author":"CE Brightling","year":"2003","unstructured":"Brightling CE, Symon FA, Birring SS: Comparison of airway immunopathology of eosinophilic bronchitis and asthma. Thorax. 2003, 58: 528-32. 10.1136\/thorax.58.6.528.","journal-title":"Thorax"},{"key":"60_CR59","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1067\/mai.2002.129698","volume":"110","author":"CE Brightling","year":"2002","unstructured":"Brightling CE, Symon FA, Birring SS: TH2 cytokine expression in bronchoalveolar lavage fluid T lymphocytes and bronchial submucosa is a feature of asthma and eosinophilic bronchitis. J Allergy Clin Immunol. 2002, 110: 899-905. 10.1067\/mai.2002.129698.","journal-title":"J Allergy Clin Immunol"},{"key":"60_CR60","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1136\/thx.2006.062141","volume":"62","author":"H Begueret","year":"2007","unstructured":"Begueret H, Berger P, Vernejoux JM: Inflammation of bronchial smooth muscle in allergic asthma. Thorax. 2007, 62: 8-15. 10.1136\/thx.2006.062141.","journal-title":"Thorax"},{"key":"60_CR61","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1111\/j.1398-9995.2005.00823.x","volume":"60","author":"K Amin","year":"2005","unstructured":"Amin K, Janson C, Boman G, Venge P: The extracellular deposition of mast cell products is increased in hypertrophic airways smooth muscles in allergic asthma but not in nonallergic asthma. Allergy. 2005, 60: 1241-7. 10.1111\/j.1398-9995.2005.00823.x.","journal-title":"Allergy"},{"key":"60_CR62","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1096\/fj.03-0041fje","volume":"17","author":"P Berger","year":"2003","unstructured":"Berger P, Girodet PO, Begueret H: Tryptase-stimulated human airway smooth muscle cells induce cytokine synthesis and mast cell chemotaxis. FASEB J. 2003, 17: 2139-41.","journal-title":"FASEB J"},{"key":"60_CR63","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.4049\/jimmunol.176.3.1860","volume":"176","author":"A El-Shazly","year":"2006","unstructured":"El-Shazly A, Berger P, Girodet PO: Fraktalkine produced by airway smooth muscle cells contributes to mast cell recruitment in asthma. J Immunol. 2006, 176: 1860-8.","journal-title":"J Immunol"},{"key":"60_CR64","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1183\/09031936.02.00275802","volume":"19","author":"NG Carroll","year":"2002","unstructured":"Carroll NG, Mutavdzic S, James AL: Distribution and degranulation of airway mast cells in normal and asthmatic subjects. Eur Respir J. 2002, 19: 879-85. 10.1183\/09031936.02.00275802.","journal-title":"Eur Respir J"},{"key":"60_CR65","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.4049\/jimmunol.176.2.1238","volume":"176","author":"W Yang","year":"2006","unstructured":"Yang W, Kaur D, Okayama Y: Human lung mast cells adhere to human airway smooth muscle, in part, via tumor suppressor in lung cancer-1. J Immunol. 2006, 176: 1238-43.","journal-title":"J Immunol"},{"key":"60_CR66","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1046\/j.1365-2222.1999.00580.x","volume":"29","author":"P Berger","year":"1999","unstructured":"Berger P, Compton SJ, Molimard M: Mast cell tryptase as a mediator of hyperresponsiveness in human isolated bronchi. Clin Exp Allergy. 1999, 29: 804-12. 10.1046\/j.1365-2222.1999.00580.x.","journal-title":"Clin Exp Allergy"},{"key":"60_CR67","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1152\/jappl.2001.91.3.1372","volume":"91","author":"P Berger","year":"2001","unstructured":"Berger P, Perng DW, Thabrew H: Tryptase and agonists of PAR-2 induce the proliferation of human airway smooth muscle cells. J Appl Physiol. 2001, 91: 1372-9.","journal-title":"J Appl Physiol"},{"key":"60_CR68","doi-asserted-by":"crossref","first-page":"L197","DOI":"10.1152\/ajplung.2002.282.2.L197","volume":"282","author":"JK Brown","year":"2002","unstructured":"Brown JK, Jones CA, Rooney LA: Tryptase's potent mitogenic effects in human airway smooth muscle cells are via non-proteolytic actions. Am J Physiol Lung Cell Mol Physiol. 2002, 282: L197-206.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"60_CR69","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1165\/ajrcmb.26.2.4600","volume":"26","author":"R Venkayya","year":"2002","unstructured":"Venkayya R, Lam M, Willkom M: The Th2 lymphocyte products IL-4 and IL-13 rapidly induce airway hyper-responsiveness through direct effects on resident airway cells. Am J Respir Cell Mol Biol. 2002, 26: 202-8.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"60_CR70","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1111\/j.1365-2222.2003.01827.x","volume":"33","author":"CE Brightling","year":"2003","unstructured":"Brightling CE, Symon FA, Holgate ST: IL-4 and IL-13 are colocalised to mast cells within airway smooth muscle in asthma. Clin Exp Allergy. 2003, 33: 1711-6. 10.1111\/j.1365-2222.2003.01827.x.","journal-title":"Clin Exp Allergy"},{"key":"60_CR71","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1189\/jlb.0904511","volume":"77","author":"CE Brightling","year":"2005","unstructured":"Brightling CE, Kaur D, Berger P: Differential expression of CCR3 and CXCR3 by human lung and bone marrow-derived mast cells: implications for tissue mast cell migration. J Leuk Biol. 2005, 77: 759-66. 10.1189\/jlb.0904511.","journal-title":"J Leuk Biol"},{"key":"60_CR72","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1136\/thx.2006.060319","volume":"61","author":"G Cruse","year":"2006","unstructured":"Cruse G, Duffy SM, Brightling CE, Bradding P: Functional KCa3.1 K+ channels are required for human lung mast cell migration. Thorax. 2006, 61: 880-5. 10.1136\/thx.2006.060319.","journal-title":"Thorax"}],"container-title":["Allergy, Asthma &amp; Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1710-1492-4-2-84.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/1710-1492-4-2-84\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1710-1492-4-2-84.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T04:39:56Z","timestamp":1685594396000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacijournal.biomedcentral.com\/articles\/10.1186\/1710-1492-4-2-84"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":72,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["60"],"URL":"https:\/\/doi.org\/10.1186\/1710-1492-4-2-84","relation":{},"ISSN":["1710-1492"],"issn-type":[{"value":"1710-1492","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,6]]},"assertion":[{"value":"15 June 2008","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"84"}}